Top Suppliers:I want be here


36703-88-5

36703-88-5 structure
36703-88-5 structure
  • Name: Isoprinosine
  • Chemical Name: Isoprinosine
  • CAS Number: 36703-88-5
  • Molecular Formula: C52H78N10O17
  • Molecular Weight: 1115.23
  • Catalog: API Immune function drug Immunomodulatory drug
  • Create Date: 2018-02-21 08:00:00
  • Modify Date: 2026-06-30 21:31:08
  • Inosine pranobex is a potent, broad-spectrum antiviral compound for HIV infection. Inosine pranobex is an immunopotentiator[1].

Name Isoprinosine
Synonyms Inosin, Verbindung mit (2-Hydroxypropyl)dimethylammonium-p-acetamidobenzoat (1:3)
inosine, compound with (2-hydroxypropyl)dimethylammonium p-acetamidobenzoate (1:3)
methisoprinol
Isoprinosina
isoprinosin
imunovir
Immunovir
isoviral
0,20μm
9-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one
Nitroglycerin Solution Impurity II:Glycerol 1,3-dinitrate solution
nosine pranobex
np113
4-acetamidobenzoic acid,9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one,1-(dimethylamino)propan-2-ol
Isoprinosine(Methisoprinol)
13mm
Isoprinosine (Nosine Pranobex)
MethisoprinoluM (Inosine pranobex)
Inosine pranobex (Imunovir
Isopranosine
0.22um
0.45um
Metisoprinol
MinistNYGF
)(1:3)
Indosine Pranobeox
Inosine, compd. with 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (salt) (1:3)
Inosine pranobex, 10 mM in DMSO
ISOPRINOSINE //BP
delimmun
viruxan
0.8um
Indosine Pranobeox,Inosiplex,Methisoprinol
ISOPRINOSINE
inosinranobex
inosiplex
Isoprinosine (Inosine Pranobex)
Isopropyl inosine
25mm
4-Acetamidobenzoic acid,9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purin-6(9H)-one,1-(Dimethylamino)propan-2-ol (3:1:3)
ntp10381
oprinosin
inosine,compd.with1-(dimethylamino)-2-propanol4-(acetylamino)benzoate(salt
Inosine, compd. with 1-(dimethylamino)-2-propanol4-(acetylamino)benzoate (salt) (1:3)OTHER CA INDEX NAMES:2-Propanol, 1-(dimethylamino)-, 4-(acetylamino)benzoate (salt),compd. with inosine (3:1)Benzoic acid, 4-(acetylamino)-, compd. with1-(dimethylamino)-2-propanol and inosine (3:3:1)
Inosine pranobexInosine pranobex
aviral
Description Inosine pranobex is a potent, broad-spectrum antiviral compound for HIV infection. Inosine pranobex is an immunopotentiator[1].
Related Catalog
References

[1]. Renoux G, et al. Isoprinosine as an immunopotentiator. J Immunopharmacol. 1979;1(3):337-56.

Boiling Point 732.8ºC at 760 mmHg
Molecular Formula C52H78N10O17
Molecular Weight 1115.23
Flash Point 397ºC
Exact Mass 1114.554688
PSA 403.10000
LogP 1.76610

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NM7461240
CAS REGISTRY NUMBER :
36703-88-5
LAST UPDATED :
199109
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C10-H12-N4-O5.3C9-H9-N-O3.3C5-H13-N-O

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
9150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 19,906,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2960 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,124,1990
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3460 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 19,906,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1970 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 19,906,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
9410 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 19,906,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,124,1990
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2960 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 19,906,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1570 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 19,906,1988
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.